foxo4 dri senolytic human trial 2024 The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI peptide-blend
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14